← All organizations

Affymax

For profitContributed to NMEWebsite ↗

Also known as: Affymax, Inc

Phase 1 Phase 2 Phase 3 Phase 4

Highest phase reached

Phase 3

First clinical trial

First marketed drug

First NDA

Last known activity

Oct 1, 2011

Acquired by Glaxo → Glaxo Wellcome → GlaxoSmithKline on Jan 1, 1995

Timeline

1980s

Jan 1, 1988
Affymax— Founded

1990s

Jan 1, 1995
Glaxo— Acquired By

2000s

Jan 1, 2000
GlaxoSmithKline— Now

2010s

Mar 27, 2012
peginesatide— NDA Organization

Drugs by trial phase (4 distinct, 17 trials)

Phase 3 (4 own, 0 via acquisition)

Indications

Studied for

Marketed drugs (1)

peginesatide

Recent trials (30)

NCT01478971CollaboratorPhase 3Oct 1, 2011
NCT00752791CollaboratorPhase 2Oct 1, 2008
NCT00752609CollaboratorPhase 2Sep 1, 2008
NCT00680043Lead sponsorPhase 2Jun 1, 2008
NCT00680043Study directorPhase 2Jun 1, 2008
NCT00629876CollaboratorPhase 1Jan 1, 2008
NCT00598442Lead sponsorPhase 3Nov 1, 2007
NCT00598442Study directorPhase 3Nov 1, 2007
NCT00597584Lead sponsorPhase 3Oct 1, 2007
NCT00598273Study directorPhase 3Oct 1, 2007
NCT00597584Study directorPhase 3Oct 1, 2007
NCT00598273Lead sponsorPhase 3Oct 1, 2007
NCT00597753Lead sponsorPhase 3Sep 1, 2007
NCT00597753Study directorPhase 3Sep 1, 2007
NCT00434330Study directorPhase 2Dec 1, 2006

Details

Founded: Palo Alto, CA, US Jan 1, 1988
First NDA: Mar 27, 2012
Last known activity: Oct 1, 2011